Quality and safety
Biomaterial manufacturing processes are subject to quality management system and Geistlich Pharma is certified according to ISO 9001 and ISO 13485 international standards.
Bone substitute devices
Geistlich Pharma produces Geistlich Bio-Oss® and Geistlich Bio-Oss® Collagen bone substitute devices.
Safety
Processes fulfil stringent safety requirements:
- Australian (and for some countries New Zealand) bovine material used exclusively; Australia and New Zealand are historically free of bovine spongiform encephalopathy (BSE) and are being ranked as countries with negligible BSE risk1
- Bone is sourced from selected and certified abattoirs and suppliers and animals with certified fitness for human consumption
- Extremity bone is the only used bovine tissue at Geistlich Pharma - a tissue with no detected BSE infectivity2
- The collagen part of Geistlich Bio-Oss® Collagen is derived exclusively from Swiss porcine tissue
Chemical and physical purification process
- Stringent and validated process standards result in a highly purified bone mineral substance of consistent quality
- Manufacturing process consists of several consecutive steps combining different modes of action with high inactivating capacity against potential infective agents
- Evaluated to reliably inactivate viruses and bacteria
- Evaluated by experts as highly effective against prions. The risk of BSE agents transmission can be regarded as negligibly low
- The applied risk reducing measures were certified by the European Directorate for the Quality of Medicines and Healthcare (EDQM) as fully compliant with the European Pharmacopoeia monograph 5.2.8 ‘Minimising the risk of transmitting TSE agents via medicinal products’ and the monograph no. 1483 on ‘Products with risk of transmitting TSE agents’ (Certificate of Suitability No. R1-CEP 2004-122-Rev 01) (TSE: transmissible spongiform encephalopathy)
Sterilisation
- Products are sterilised by gamma irradiation
- Geistlich Bio-Oss® and Geistlich Bio-Oss® Collagen are provided sterile in double-layer packaging
Allergic reaction
- Allergic reactions are highly unlikely because Geistlich Bio-Oss® does not contain organic components
- Geistlich Bio-Oss® Collagen contains collagen; allergic reactions and inflammatory tissue reactions may occur in rare cases. The product should not be used in patients with known allergy towards collagen
Porcine collagen membranes and matrices
Geistlich Pharma produces the porcine collagen-based materials Geistlich Bio-Gide®, Geistlich Bio-Gide® Perio, Geistlich Mucograft® and Geistlich Mucograft® Seal. Geistlich products are subject to validated manufacturing and strict quality assurance standards.
Production of Geistlich Bio-Gide® fulfils stringent safety requirements.
01/05
Safety
Geistlich Bio-Gide®, Geistlich Bio-Gide® Perio, Geistlich Mucograft® and Geistlich Mucograft® Seal fulfil strict safety requirements.
- Produced exclusively from Swiss porcine tissue
- Processing of collagen for medical use is subject to strict safety regulations
Chemical purification process
- Fat and other unwanted tissue components are removed in an intensive multi-stage purification process
- Potential micro-organisms are inactivated
- The process results in a highly purified collagen structure
- Regular inspection of production processes by independent institutions and government authorities
Sterilisation
- Products are sterilised by gamma irradiation
- Geistlich Bio-Gide®, Geistlich Bio-Gide® Perio, Geistlich Mucograft® and Geistlich Mucograft® Seal are provided sterile in double-layer packaging
Allergic reaction
- Geistlich Bio-Gide®, Geistlich Bio-Gide® Perio, Geistlich Mucograft® and Geistlich Mucograft® Seal contain collagen; allergic reactions and inflammatory tissue reactions may occur in rare cases. Products should not be used in patients with known allergy to collagen
